
Recent Federal Actions Put US, Massachusetts Biotech Leadership at Risk: MassBio
Recent federal actions including large-scale FDA staff reductions and deep cuts to National Institutes of Health research could severely disrupt the U.S. biotech ecosystem, especially in Massachusetts, according to a MassBio report released May 6. The …